CRP and COVID-19: Tornero et al. 24 further observed the effect of VNS on patients with severe coronavirus disease 2019 (COVID-19): VNS therapy for 5 days significantly reduced inflammatory markers, specifically C-reactive protein and procalcitonin, with satisfactory safety.